Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-10 MAIN ALAN J EVP, Innov & Chem Sciences Grant or award · Stock Option (Right to Buy) +230,990 230,990
2022-02-10 MAIN ALAN J EVP, Innov & Chem Sciences Grant or award · Restricted Stock Units +77,000 77,000
2022-02-10 Seth Kiernan VP, Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +206,670 206,670
2022-02-10 Seth Kiernan VP, Chief Commercial Officer Grant or award · Restricted Stock Units +68,890 68,890
2022-02-10 WADE JEFFREY L President and CFO Grant or award · Stock Option (Right to Buy) +335,470 335,470
2022-02-10 WADE JEFFREY L President and CFO Grant or award · Restricted Stock Units +111,820 111,820
2022-02-10 Kassler-Taub Kenneth B. SVP, Regulatory & QA Grant or award · Stock Option (Right to Buy) +248,010 248,010
2022-02-10 Kassler-Taub Kenneth B. SVP, Regulatory & QA Grant or award · Restricted Stock Units +82,670 82,670
2022-02-10 COATS LONNEL Chief Executive Officer Grant or award · Stock Option (Right to Buy) +822,280 822,280
2022-02-10 COATS LONNEL Chief Executive Officer Grant or award · Restricted Stock Units +274,090 274,090
2022-02-10 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +251,250 251,250
2022-02-10 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Restricted Stock Units +83,750 83,750
2022-02-10 Crum Brian T SVP, General Counsel & Secr. Grant or award · Stock Option (Right to Buy) +234,870 234,870
2022-02-10 Crum Brian T SVP, General Counsel & Secr. Grant or award · Restricted Stock Units +78,290 78,290
2022-02-10 Alexander Kristen VP, Finance and Accounting Grant or award · Stock Option (Right to Buy) +47,780 47,780
2022-02-10 Alexander Kristen VP, Finance and Accounting Grant or award · Restricted Stock Units +31,850 31,850
2022-01-03 McDermott Wendy VP, Human Resources Grant or award · Stock Option (Right to Buy) +85,185 85,185
2021-08-02 Granowitz Craig B SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000
2021-04-30 SOBECKI CHRISTOPHER J Director Grant or award · Restricted Stock Units +4,024 4,024
2021-04-30 SOBECKI CHRISTOPHER J Director Grant or award · Stock Option (Right to Buy) +6,475 6,475

Page 26 of 27 · 540 trades